Facicare Cream is a topical formulation containing Hydroquinone (2% w/w), Mometasone (0.1% w/w), and Tretinoin (0.025% w/w), designed to effectively treat various dermatological conditions such as hyperpigmentation, melasma, and inflammatory skin disorders. Hydroquinone acts as a skin-lightening agent by inhibiting tyrosinase, an enzyme involved in melanin production, thereby reducing dark spots and uneven skin tone. Mometasone, a potent corticosteroid, provides anti-inflammatory and immunosuppressive effects, helping to alleviate redness, swelling, and irritation associated with skin conditions. Tretinoin, a retinoid derivative of vitamin A, promotes skin cell turnover and exfoliation, enhancing the penetration of active ingredients and improving skin texture and tone. The combination of these three active ingredients makes Facicare Cream a powerful treatment option for patients with stubborn pigmentation and inflammatory dermatoses. It is recommended for use under medical supervision due to the presence of corticosteroids and retinoids, which may cause side effects such as skin thinning, irritation, or photosensitivity if misused. Patients should apply the cream as directed, avoid excessive sun exposure, and use sunscreen to protect treated areas. Facicare Cream offers a comprehensive approach to managing complex skin conditions by targeting pigmentation, inflammation, and cellular renewal simultaneously.